Scarica l'app Stockscreener
0.3794
6.48%
-0.0263
Dopo l'orario di chiusura:
.41
0.0306
+8.07%
Neumora Therapeutics Inc Azioni (NMRA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Operating Expenses |
20.19%
42.19
|
52.86 | 58.48 | 57.70 | 54.04 |
| Interest Income/Expense |
0.70%
1.426
|
1.436 | - | - | - |
| Operating Income/Loss |
20.19%
-42.19
|
-52.86 | -58.48 | -57.70 | -54.04 |
| Nonoperating Income/Loss |
58.16%
-0.892
|
-0.564 | -0.97 | 0.945 | 1.334 |
| Income/Loss From Continuing Operations Before Tax |
19.36%
-43.08
|
-53.43 | -59.45 | -56.76 | -52.71 |
| Income Tax Expense/Benefit |
100.00%
-
|
0.03 | - | - | 0.025 |
| Net Income/Loss |
19.41%
-43.08
|
-53.46 | -59.45 | -56.76 | -52.73 |
| Basic Average Shares |
2.94%
185.16
|
179.87 | - | 161.84 | 161.69 |
| Diluted Average Shares |
2.94%
185.16
|
179.87 | - | 161.84 | 161.69 |
| Basic Earnings Per Share |
23.33%
-0.23
|
-0.30 | - | -0.35 | -0.33 |
| Diluted Earnings Per Share |
23.33%
-0.23
|
-0.30 | - | -0.35 | -0.33 |
3.09%
0.72%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):